Ib Jarle Christensen
- Cancer Research top 0.2%
- Protease and Inhibitor Mechanisms 67
- Cancer Genomics and Diagnostics 29
- Oncology top 0.2%
- Peptidase Inhibition and Analysis 60
- Colorectal Cancer Screening and Detection 32
- Colorectal Cancer Treatments and Studies 31
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment 41
- Immunology top 0.5%
- Obstetrics and Gynecology top 0.5%
-
- Genetic factors in colorectal cancer 46
-
- Cell Adhesion Molecules Research 31
- Co-authors
- Lars L. VindeløvNis I. NissenHans Jørgen NielsenNils BrünnerClaus HøgdallJulia S. JohansenEstrid HøgdallGunilla Høyer‐Hansen
- Journals
- Journal of Clinical Oncology (17 papers)SHILAP Revista de lepidopterología (3 papers)The EMBO Journal (2 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Ib Jarle Christensen
437 papers receiving 14.9k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 4.0k
- Oncology 5.6k
- Reproductive Medicine 1.3k
- Immunology 2.5k
- Obstetrics and Gynecology 789
Countries citing papers authored by Ib Jarle Christensen
This map shows the geographic impact of Ib Jarle Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ib Jarle Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ib Jarle Christensen more than expected).
Fields of papers citing papers by Ib Jarle Christensen
This network shows the impact of papers produced by Ib Jarle Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ib Jarle Christensen. The network helps show where Ib Jarle Christensen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ib Jarle Christensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2020 | 9 | |
| 6 | 2019 | 11 | |
| 7 | 2019 | 1 | |
| 8 | 2015 | 16 | |
| 9 | 2015 | 25 | |
| 10 | 2014 | 30 | |
| 11 | 2011 | 30 | |
| 12 | 2010 | 2 | |
| 13 | 2010 | 18 | |
| 14 | 2008 | 64 | |
| 15 | 2006 | 0 | |
| 16 | 2006 | 11 | |
| 17 | [Serological markers of colorectal cancer]. | 2005 | 2 |
| 18 | 1999 | 202 | |
| 19 | 1993 | 7 | |
| 20 | Treatment of pseudarthrosis of the long bones in Denmark. | 1955 | 3 |
About Ib Jarle Christensen
Ib Jarle Christensen is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 446 papers that have together received 15.3k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (67 papers), Peptidase Inhibition and Analysis (60 papers), Genetic factors in colorectal cancer (46 papers), Ovarian cancer diagnosis and treatment (41 papers), Colorectal Cancer Screening and Detection (32 papers), Cell Adhesion Molecules Research (31 papers), Colorectal Cancer Treatments and Studies (31 papers) and Cancer Genomics and Diagnostics (29 papers). The work is most often cited by research in Cancer Research (4.0k citations), Oncology (5.6k citations) and Reproductive Medicine (1.3k citations). Ib Jarle Christensen has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Lars L. Vindeløv, Nis I. Nissen, Hans Jørgen Nielsen, Nils Brünner, Claus Høgdall, Julia S. Johansen, Estrid Høgdall, Gunilla Høyer‐Hansen, Paul A. Price and Nils Brünner. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.